United States (US) Gram-positive Bacterial Infections Market (2026-2032) | Growth, Value, Competitive Landscape, Trends, Analysis, Companies, Outlook, Share, Industry, Size & Revenue, Segmentation, Forecast

Market Forecast By Drug Type (Antibiotic, Antifungal, Others), By Disease (MRSA, Pneumonia, Sepsis, Sinusitis, Cellulitis, Otitis, Others), By Route of Administration (Enteral, Parenteral, Others (Topical, Transdermal)), By Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Others) And Competitive Landscape
Product Code: ETC9967123 Publication Date: Sep 2024 Updated Date: Apr 2026 Product Type: Market Research Report
Publisher: 6Wresearch Author: Shubham Padhi No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

United States (US) Gram-positive Bacterial Infections Market Top 5 Importing Countries and Market Competition (HHI) Analysis

The United States continues to be a key importer of gram-positive bacterial infection treatments, with significant shipments coming from top exporting countries such as India, Switzerland, Canada, Australia, and China in 2024. The market shows a high concentration with a very high Herfindahl-Hirschman Index (HHI) in 2024, indicating a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 is strong at 16.58%, with an impressive growth rate of 68.96% in 2024 alone, underscoring the increasing demand for these treatments in the US market.

United States (US) Gram-positive Bacterial Infections Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

  • United States (US) Gram-positive Bacterial Infections Market Outlook
  • Market Size of United States (US) Gram-positive Bacterial Infections Market, 2025
  • Forecast of United States (US) Gram-positive Bacterial Infections Market, 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Revenues & Volume for the Period 2022 - 2032
  • United States (US) Gram-positive Bacterial Infections Market Trend Evolution
  • United States (US) Gram-positive Bacterial Infections Market Drivers and Challenges
  • United States (US) Gram-positive Bacterial Infections Price Trends
  • United States (US) Gram-positive Bacterial Infections Porter's Five Forces
  • United States (US) Gram-positive Bacterial Infections Industry Life Cycle
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Drug Type for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Antibiotic for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Antifungal for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Others for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Disease for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By MRSA for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Pneumonia for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Sepsis for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Sinusitis for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Cellulitis for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Otitis for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Others for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Route of Administration for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Enteral for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Parenteral for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Others (Topical, Transdermal) for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Distribution Channel for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Hospitals Pharmacies for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Drug Stores and Retail Pharmacies for the Period 2022 - 2032
  • Historical Data and Forecast of United States (US) Gram-positive Bacterial Infections Market Revenues & Volume By Others for the Period 2022 - 2032
  • United States (US) Gram-positive Bacterial Infections Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Type
  • Market Opportunity Assessment By Disease
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By Distribution Channel
  • United States (US) Gram-positive Bacterial Infections Top Companies Market Share
  • United States (US) Gram-positive Bacterial Infections Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Gram-positive Bacterial Infections Company Profiles
  • United States (US) Gram-positive Bacterial Infections Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Gram-positive Bacterial Infections Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Gram-positive Bacterial Infections Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Gram-positive Bacterial Infections Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, 2022 & 2032F

3.3 United States (US) Gram-positive Bacterial Infections Market - Industry Life Cycle

3.4 United States (US) Gram-positive Bacterial Infections Market - Porter's Five Forces

3.5 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume Share, By Drug Type, 2022 & 2032F

3.6 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume Share, By Disease, 2022 & 2032F

3.7 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F

3.8 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F

4 United States (US) Gram-positive Bacterial Infections Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of gram-positive bacterial infections in the United States

4.2.2 Rising awareness about the importance of appropriate antibiotic use and infection control measures

4.2.3 Technological advancements leading to the development of novel treatments and diagnostics for gram-positive bacterial infections

4.3 Market Restraints

4.3.1 Growing antibiotic resistance among gram-positive bacteria

4.3.2 High costs associated with the development and commercialization of new therapies

4.3.3 Stringent regulatory requirements for drug approval in the field of infectious diseases

5 United States (US) Gram-positive Bacterial Infections Market Trends

6 United States (US) Gram-positive Bacterial Infections Market, By Types

6.1 United States (US) Gram-positive Bacterial Infections Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Type, 2022 - 2032F

6.1.3 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By Antibiotic, 2022 - 2032F

6.1.4 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By Antifungal, 2022 - 2032F

6.1.5 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2022 - 2032F

6.2 United States (US) Gram-positive Bacterial Infections Market, By Disease

6.2.1 Overview and Analysis

6.2.2 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By MRSA, 2022 - 2032F

6.2.3 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By Pneumonia, 2022 - 2032F

6.2.4 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By Sepsis, 2022 - 2032F

6.2.5 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By Sinusitis, 2022 - 2032F

6.2.6 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By Cellulitis, 2022 - 2032F

6.2.7 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By Otitis, 2022 - 2032F

6.3 United States (US) Gram-positive Bacterial Infections Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By Enteral, 2022 - 2032F

6.3.3 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By Parenteral, 2022 - 2032F

6.3.4 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By Others (Topical, Transdermal), 2022 - 2032F

6.4 United States (US) Gram-positive Bacterial Infections Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By Hospitals Pharmacies, 2022 - 2032F

6.4.3 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2022 - 2032F

6.4.4 United States (US) Gram-positive Bacterial Infections Market Revenues & Volume, By Others, 2022 - 2032F

7 United States (US) Gram-positive Bacterial Infections Market Import-Export Trade Statistics

7.1 United States (US) Gram-positive Bacterial Infections Market Export to Major Countries

7.2 United States (US) Gram-positive Bacterial Infections Market Imports from Major Countries

8 United States (US) Gram-positive Bacterial Infections Market Key Performance Indicators

8.1 Rate of antibiotic resistance development in gram-positive bacteria

8.2 Adoption rate of new treatment guidelines for gram-positive bacterial infections

8.3 Number of research and development collaborations focused on gram-positive bacterial infections

8.4 Patient adherence to prescribed antibiotic regimens

9 United States (US) Gram-positive Bacterial Infections Market - Opportunity Assessment

9.1 United States (US) Gram-positive Bacterial Infections Market Opportunity Assessment, By Drug Type, 2022 & 2032F

9.2 United States (US) Gram-positive Bacterial Infections Market Opportunity Assessment, By Disease, 2022 & 2032F

9.3 United States (US) Gram-positive Bacterial Infections Market Opportunity Assessment, By Route of Administration, 2022 & 2032F

9.4 United States (US) Gram-positive Bacterial Infections Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F

10 United States (US) Gram-positive Bacterial Infections Market - Competitive Landscape

10.1 United States (US) Gram-positive Bacterial Infections Market Revenue Share, By Companies, 2025

10.2 United States (US) Gram-positive Bacterial Infections Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Leadership Perspectives from Industry Events

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Industry Events and Analyst Meet

Whitepaper

Read All